INP104
Impel Pharmaceuticals
['apa ']
today at #aanam we re presenting an analysis using a model-based approach that found no ddis of clinical concern are theoretically predicted if trudhesa and gepants are co-administered within recommended clinical doses. abstract: #neurotwitter #migraine 
Developing life-changing, innovative therapies for diseases with unmet needs